Idenix Pharmaceuticals (IDIX)

[keitern]

As they say, the devil is in the details. I am happy to see that NVS will now be accountable for 100% of the Tyzeka expenses. I find it hard to believe that NVS will now spend 80-100 million in the US alone annualy for Tyzeka. By who's accounting was this supposed 50% being enforced? I bet NVS had quite a bit of leverage in this prior relationship. I have a hunch that this whole US Tyzeka program will cost NVS about 50 million annualy, maybe not even that much, but that is just a hunch.
Now it all depends on the royalty arrangement. How arrogant of them not to let the shareholders (owners - LOL) know about the quantitative side of this. These kind of deals and non-disclosures increases the risk that some may be able to take unfair advantage.